» Articles » PMID: 20514528

Histopathology of Lupus Nephritis

Overview
Date 2010 Jun 2
PMID 20514528
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The spectrum of morphologic changes in lupus nephritis, either microscopic, ultrastructural, or immunohistological, closely reflects the great variety of immune complexes that are produced in the course of the disease. Every tissue component of the kidney can be affected, but glomeruli are the target structure in most patients. Several attempts have been made to correlate the clinical severity and the outcome of the nephritis with the pathologic features; the current classification and the six classes that resulted from an international study group are entirely based on glomerular changes. Major criteria of classification include the focal or diffuse involvement of the glomerulus, the site of hypercellularity, the site of immune complex deposition and the presence of active and/or sclerotic lesions. Even if less thoroughly investigated than the glomerulus, the interstitial compartment has revealed many interesting features as are vascular lesions, a common and often underestimated feature. Typing of subpopulation of lymphoid infiltrates supports the emerging evidence indicating that B cells are promoting autoimmunity in mechanisms other than autoAb secretion. Many aspects are still debated and/or poorly understood, such as the interpretation of the so-called "full house nephropathy" that closely mimic lupus nephritis in seronegative patients.

Citing Articles

STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.

Zhu J, Chen Y, Chen Y, Lv Y, Chen T Ren Fail. 2024; 46(1):2358187.

PMID: 38803234 PMC: 11136473. DOI: 10.1080/0886022X.2024.2358187.


Nonlupus Full House Nephropathy: A Systematic Review.

Uzzo M, Kronbichler A, Alberici F, Bajema I Clin J Am Soc Nephrol. 2024; 19(6):743-754.

PMID: 38527995 PMC: 11168831. DOI: 10.2215/CJN.0000000000000438.


Prediction of treatment response in lupus nephritis using density of tubulointerstitial macrophage infiltration.

Wang J, Lou W, Zhu M, Tu Y, Chen D, Qiu D Front Immunol. 2024; 15:1321507.

PMID: 38415246 PMC: 10896899. DOI: 10.3389/fimmu.2024.1321507.


Spectrum of Morphologic Features of Lupus Nephritis According to Nephrology/Renal Pathology Society (ISN/RPS) Classification.

Hashmi A, Ali J, Rahman M, Taseer A, Kumar J, Irfan M Cureus. 2020; 12(9):e10520.

PMID: 33094061 PMC: 7574832. DOI: 10.7759/cureus.10520.


Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.

Aguirre-Valencia D, Rios-Serna L, Posso-Osorio I, Naranjo-Escobar J, Lopez D, Bedoya-Joaqui V J Transl Autoimmun. 2020; 3:100027.

PMID: 32743512 PMC: 7388398. DOI: 10.1016/j.jtauto.2019.100027.


References
1.
Schwartz M, Korbet S, Katz R, Lewis E . Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis. Lupus. 2009; 18(2):149-58. DOI: 10.1177/0961203308095947. View

2.
KLEMPERER P . The pathogenesis of lupus erythematosus and allied conditions. Ann Intern Med. 1948; 28(1):1-11. DOI: 10.7326/0003-4819-28-1-1. View

3.
Hill G, Delahousse M, Nochy D, Bariety J . Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 2005; 68(5):2288-97. DOI: 10.1111/j.1523-1755.2005.00688.x. View

4.
Korbet S, Lewis E, Schwartz M, Reichlin M, Evans J, Rohde R . Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000; 35(5):904-14. DOI: 10.1016/s0272-6386(00)70262-9. View

5.
Papadimitraki E, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I . Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006; 54(11):3601-11. DOI: 10.1002/art.22197. View